Table 1 Impact of COVID-19 on NF clinic patient volume
From: The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research
Estimated patient volume in April 2020 compared to pre-COVID-19 pandemic (n = 52) | |
|---|---|
0% | 3 (5.8%) |
1–25% | 15 (28.9%) |
26–50% | 16 (30.8%) |
51–75% | 7 (13.5%) |
76–100% | 9 (17.3%) |
> 100% | 2 (3.9%) |
Estimated percentage of clinic patient volume delivered by telehealth (n = 49*) | |
|---|---|
100% | 5 (10.2%) |
75–99% | 32 (65.3%) |
50–74% | 5 (10.2%) |
25–49% | 5 (10.2%) |
0–24% | 2 (4.0%) |